dexmedetomidine has been researched along with Psychotic Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Citrome, L; De Vivo, M; Finman, J; Kakar, R; Krystal, JH; Lauriello, J; Preskorn, SH; Rajachandran, L; Risinger, R; Yocca, FD | 1 |
| Bueno, H; Cortés-Beringola, A; Domínguez-Pérez, L; Martín-Asenjo, R; Maruri, R; Moreno, G; Puerto, E; Vicent, L; Vidán, MT | 1 |
1 review(s) available for dexmedetomidine and Psychotic Disorders
| Article | Year |
|---|---|
Diagnosis, prevention, and management of delirium in the intensive cardiac care unit.
Topics: Antipsychotic Agents; Coronary Care Units; Delirium; Dementia; Depression; Dexmedetomidine; Diagnosis, Differential; Humans; Hypnotics and Sedatives; Psychotic Disorders; Risk Assessment | 2021 |
1 trial(s) available for dexmedetomidine and Psychotic Disorders
| Article | Year |
|---|---|
Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Antipsychotic Agents; Dexmedetomidine; Double-Blind Method; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Sleepiness; Treatment Outcome | 2022 |